Skip to main content

Advertisement

SpringerLink
Log in

Mixology: seeking the right prescription for atrial fibrillation

  • Commentary
  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tardos JG, Ronk CJ, Patel MY, Koren A, Kim MH. US antiarrhythmic drug treatment for patients with atrial fibrillation: an insurance claims-based report. J Am Heart Assoc. 2021;10(6):e016792. https://doi.org/10.1161/JAHA.120.016792.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics – 2022 update: a report from the American Heart Association. Circulation. 2022;145:e153–639. https://doi.org/10.1161/CIR.0000000000001052.

    Article  PubMed  Google Scholar 

  3. LaMori JC, Mody SH, Gross HJ, DiBonaventura MD, Patel AA, Schein JR, Nelson WW. Burden of comorbidities among patients with atrial fibrillation. Ther Adv Cardiovasc Dis. 2013;7(2):53–62.

    Article  PubMed  Google Scholar 

  4. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland Jr JC, Ellinor PT, Ezekowitz MD, Field MD, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW, 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Heart Rhythm. 2019;16:e66–93. https://doi.org/10.1016/j.hrthm.2019.01.024.

  5. National Center for Health Statistics. Health, United States, 2019: Figure 39. Hyattsville, MD. 2019. Available from: https://www.cdc.gov/nchs/hus/data-finder.htm. Accessed 12 Aug 2022.

  6. Shurrab M, Jackevicius CA, Austin PC, Tu K, Qiu F, Caswell J, Michael F, Andrade JG, Ko DT. Association between concurrent use of diltiazem and DOACs and risk of bleeding in atrial fibrillation patients. J Interv Card Electrophysiol. In press.

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center at Houston, 6431 Fannin, MSB 1.246, TX, Houston, 77030, USA

    Anne Hamilton Dougherty

Authors
  1. Anne Hamilton Dougherty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anne Hamilton Dougherty.

Ethics declarations

Ethical approval

Not applicable.

Conflict of interest

Anne Dougherty receives cardiac electrophysiology fellowship support from Abbott Laboratories, Medtronic, Boston Scientific, and Biosense Webster Inc.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This comment refers to the article available at https://doi.org/10.1007/s10840-022-01355-1

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dougherty, A.H. Mixology: seeking the right prescription for atrial fibrillation. J Interv Card Electrophysiol 66, 1303–1304 (2023). https://doi.org/10.1007/s10840-022-01415-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-022-01415-6

Search

Navigation